Skip to main content

Table 2 Number of prescribed anti-hypertensive compounds at baseline and at audit’s end

From: How many hypertensive patients can be controlled in “real life”: an improvement strategy in primary care

 

Baseline

(mean ± SD, range)

Study’s end

(mean ± SD, range)

p

Total hypertensive population

1.17 ± 0.81 (0-7)

1.18 ± 0.82 (0-7)

< 0.001

Controlled

1.25 ± 0.76 (0-7)

1.27 ± 0.76 (0-5)

< 0.001

Non controlled

1.25 ± 0.87 (0-5)

1.27 ± 0.85 (0-6)

< 0.001

Without final BP recording

0.88 ± 0.86 (0-6)

0.85 ± 0.88 (0-7)

< 0.001

Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us